Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)

Summary

Background: Anaemia in pregnancy is a public health burden with high incidence in Africa. Currently high dose oral iron is recommended for treatment of mild to moderate anaemia and blood transfusion for severe anaemia. The high dose oral iron is often poorly tolerated and associated with several side effects. Various parenteral iron preparations are now available for treatment of iron deficiency anaemia (IDA). The earliest of these, iron dextran is not commonly used because of its potential to cause anaphylactic reactions. Newer preparations have been found to be safer and their use for treatment of IDA is currently being evaluated. Objective: This study sought out to compare the effectiveness of intravenous ferric carboxymaltose (intervention) versus oral ferrous sulphate (control) for treating IDA in pregnancy and to compare the tolerability, safety and the cost-effectiveness of intravenous versus oral iron among pregnant Nigerian women with moderate and severe IDA at 20-32 weeks' gestation. Methodology: This study will be a hybrid Type 1 effectiveness-implementation design. 1056 eligible and consenting pregnant women with anaemia at 20 - 32 weeks gestation will be recruited. They will be randomized into either of 2 groups. Group A will have intravenous ferric carboxymaltose 20mg/kg to a maximum of 1000mg in 200mls of normal saline infusion over 15 - 20 minutes at enrolment. Group B will have oral ferrous sulphate 200mg (65mg elemental iron) thrice daily from enrolment till delivery. They will be followed up through delivery and until 6 weeks post partum. Their haemoglobin concentration, full blood count, serum ferritin and serum transferrin will be assayed at specific intervals using standard laboratory techniques. Depression will be assessed at each visit using Edinburg Postnatal Depression Scale. Cost effectiveness analysis will also be done at each visit. The primary outcome measure will be incidence of maternal anaemia and rise in haemoglobin level. Secondary outcome measures will include safety and tolerability of trial drugs, severe maternal events, incidence of infant low birth weight and incidence of depression. Statistical analysis will be done using STATA version 16.0 statistical software (STATACorp, Texas, USA).

Timeline

Start

2021-08-09

Primary completion

2023-04-05

Completion

2023-06-15

Publications

• Background WHO. The global prevalence of anemia in 2011. Geneva: World Health Organization. 2011 [Available from: https://apps.who.int/iris/bitstream/handle/10665/177094/9789241564960_eng.pdf,accessed?sequence=1.
• Background Balarajan Y, Ramakrishnan U, Ozaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and middle-income countries. Lancet. 2011 Dec 17;378(9809):2123-35. doi: 10.1016/S0140-6736(10)62304-5. Epub 2011 Aug 1.
• Background Parks S, Hoffman MK, Goudar SS, Patel A, Saleem S, Ali SA, Goldenberg RL, Hibberd PL, Moore J, Wallace D, McClure EM, Derman RJ. Maternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan. BJOG. 2019 May;126(6):737-743. doi: 10.1111/1471-0528.15585. Epub 2019 Jan 24.
• Background Kang SY, Kim HB, Sunwoo S. Association between anemia and maternal depression: A systematic review and meta-analysis. J Psychiatr Res. 2020 Mar;122:88-96. doi: 10.1016/j.jpsychires.2020.01.001. Epub 2020 Jan 8.
• Background Dama M, Van Lieshout RJ, Mattina G, Steiner M. Iron Deficiency and Risk of Maternal Depression in Pregnancy: An Observational Study. J Obstet Gynaecol Can. 2018 Jun;40(6):698-703. doi: 10.1016/j.jogc.2017.09.027. Epub 2018 Jan 4.
• Background WHO. Treatments for iron-deficiency anemia in pregnancy. 2007 [Available from: https://extranet.who.int/rhl/topics/pregnancy-and-childbirth/medical-problems-during-pregnancy/anaemia-during-pregnancy/treatments-iron-deficiency-anaemia-pregnancy
• Background Auerbach M, Gafter-Gvili A, Macdougall IC. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020 Apr;7(4):e342-e350. doi: 10.1016/S2352-3026(19)30264-9.
• Background Radhika AG, Sharma AK, Perumal V, Sinha A, Sriganesh V, Kulshreshtha V, Kriplani A. Parenteral Versus Oral Iron for Treatment of Iron Deficiency Anaemia During Pregnancy and post-partum: A Systematic Review. J Obstet Gynaecol India. 2019 Feb;69(1):13-24. doi: 10.1007/s13224-018-1191-8. Epub 2019 Jan 17.
• Background WHO. Trends in Maternal Mortality: 2000-2017 2019 [Available from: https://apps.who.int/iris/bitstream/handle/10665/327595/9789241516488-eng.pdf?ua=1
• Background National Population Commission Nigeria. National Demographic and Health Survey Nigeria 2018 [Available from: https://dhsprogram.com/pubs/pdf/FR359/FR359.pdf
• Background Vanderjagt DJ, Brock HS, Melah GS, El-Nafaty AU, Crossey MJ, Glew RH. Nutritional factors associated with anaemia in pregnant women in northern Nigeria. J Health Popul Nutr. 2007 Mar;25(1):75-81.
• Background Bukar M, Audu B, Sadauki H, El-Nafaty AU, Mairiga A. Prevalence of iron deficiency and megaloblastic anemia at booking in a secondary health facility in north eastern Nigeria. Nigerian Medical Journal. 2009;50(2):33-7.
• Background Erhabor O, Isaac I, Isah A, Udomah F. Iron Deficiency Anemia among Antenatal Women in Sokoto, Nigeria. British Journal of Medical and Health Sciences. 2013;1(4):47-57.
• Background Ajepe AA, Okunade KS, Sekumade AI, Daramola ES, Beke MO, Ijasan O, Olowoselu OF, Afolabi BB. Prevalence and foetomaternal effects of iron deficiency anaemia among pregnant women in Lagos, Nigeria. PLoS One. 2020 Jan 23;15(1):e0227965. doi: 10.1371/journal.pone.0227965. eCollection 2020.
• Background Okafor I, Ibanga I, Asuquo J. Prevalence of Anemia and Iron Deficiency Anemia among Pregnant Women in a Nigerian Rural Community. Sokoto Journal of Medical Laboratory Science. 2018;3(2):52-8.
• Background Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, Pena-Rosas JP, Bhutta ZA, Ezzati M; Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013 Jul;1(1):e16-25. doi: 10.1016/S2214-109X(13)70001-9. Epub 2013 Jun 25.
• Background Auerbach M. Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron. Reprod Health. 2018 Jun 22;15(Suppl 1):96. doi: 10.1186/s12978-018-0536-1.
• Background Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD004736. doi: 10.1002/14651858.CD004736.pub5.
• Background Qassim A, Grivell RM, Henry A, Kidson-Gerber G, Shand A, Grzeskowiak LE. Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust. 2019 Oct;211(8):367-373. doi: 10.5694/mja2.50308. Epub 2019 Aug 22.
• Background Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. On the relative safety of parenteral iron formulations. Nephrol Dial Transplant. 2004 Jun;19(6):1571-5. doi: 10.1093/ndt/gfh185.
• Background Pollock RF, Muduma G. A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000. Clinicoecon Outcomes Res. 2017 Aug 10;9:475-483. doi: 10.2147/CEOR.S139525. eCollection 2017.
• Background Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA. 2020 Feb 4;323(5):432-443. doi: 10.1001/jama.2019.22450.
• Background Consolidated Framework for Implementation Research (CFIR). Interview Guide Tool 2020 [Available from: https://cfirguide.org/guide/app/#/.
• Background Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.
• Background Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
• Background Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.
• Background Demographic Statistics Bulletin. Nigeria: National Bureau of Statistics; 2018.
• Background Macrotrends. Lagos, Nigeria Metro Area Population 1950-2020 2020 [Available from: https://www.macrotrends.net/cities/22007/lagos/population.
• Background Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005 Dec;106(6):1335-40. doi: 10.1097/01.AOG.0000185260.82466.b4.
• Background Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J; FER-ASAP investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017 May 24;45(4):443-453. doi: 10.1515/jpm-2016-0050.
• Background Bolarinwa OA. Sample size estimation for health and social science researchers: The principles and considerations for different study designs. Niger Postgrad Med J. 2020 Apr-Jun;27(2):67-75. doi: 10.4103/npmj.npmj_19_20.
• Background Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2013 Feb;39(2):504-10. doi: 10.1111/j.1447-0756.2012.01982.x. Epub 2012 Aug 26.
• Background Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013 Jun 21;346:f3443. doi: 10.1136/bmj.f3443.
• Background Chandrasekaran N, De Souza LR, Urquia ML, Young B, Mcleod A, Windrim R, Berger H. Is anemia an independent risk factor for postpartum depression in women who have a cesarean section? - A prospective observational study. BMC Pregnancy Childbirth. 2018 Oct 11;18(1):400. doi: 10.1186/s12884-018-2032-6.
• Background Ehlken B, Nathell L, Gohlke A, Bocuk D, Toussi M, Wohlfeil S. Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase between 2014 and 2017. Drug Saf. 2019 Mar;42(3):463-471. doi: 10.1007/s40264-018-0769-5.
• Background Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health. 2015 Mar;18(2):161-72. doi: 10.1016/j.jval.2015.02.001.
• Background Common Terminology Criteria for Adverse Events (CTCAE); version 5.0. Published: November 27, 2017. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES; National Institutes of Health; National Cancer Institute.
• Akinajo OR, Annerstedt KS, Santos MT, Afolabi BB, Banke-Thomas A. Intravenous ferric carboxymaltose versus oral ferrous sulphate for iron deficiency anaemia in pregnancy in Nigeria: a cost-utility analysis. Lancet Obstet Gynaecol Womens Health. 2026 Jun;2(6):e524-e534. doi: 10.1016/S3050-5038(26)00049-X.
• Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, Akinajo OR, Galadanci HS, Quao RA, Adelabu H, Sam-Agudu NA, Adaramoye VO, Abubakar A, Banigbe B, Olorunfemi G, Benova L, Larsson EC, Annerstedt KS, Hanson C, Thornton J; IVON Trial Investigators. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Lancet Glob Health. 2024 Oct;12(10):e1649-e1659. doi: 10.1016/S2214-109X(24)00239-0.
• Akinajo OR, Babah OA, Banke-Thomas A, Benova L, Sam-Agudu NA, Balogun MR, Adaramoye VO, Galadanci HS, Quao RA, Afolabi BB, Annerstedt KS. Acceptability of IV iron treatment for iron deficiency anaemia in pregnancy in Nigeria: a qualitative study with pregnant women, domestic decision-makers, and health care providers. Reprod Health. 2024 Feb 13;21(1):22. doi: 10.1186/s12978-024-01743-y.
• Afolabi BB, Babah OA, Akinajo OR, Adaramoye VO, Adeyemo TA, Balogun M, Banke-Thomas A, Quao RA, Olorunfemi G, Abioye AI, Galadanci HS, Sam-Agudu NA. Intravenous versus oral iron for iron deficiency anaemia in pregnant Nigerian women (IVON): study protocol for a randomised hybrid effectiveness-implementation trial. Trials. 2022 Sep 8;23(1):763. doi: 10.1186/s13063-022-06690-2.

Drugs

Indications